SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT GLYCOSYLATED INTERLEUKIN 6 IN PATIENTS WITH CANCER: PHARMACOKINETICS, PHARMACODYNAMICS AND IMMUNOMODULATORY EFFECTS-Reference-Cited by-同舟云学术

SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT GLYCOSYLATED INTERLEUKIN 6 IN PATIENTS WITH CANCER: PHARMACOKINETICS, PHARMACODYNAMICS AND IMMUNOMODULATORY EFFECTS

Published:2000-04 Issue:4 Volume:12 Page:388-396
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Banks Rosamonde E,Forbes Mary A,Patel Poulam M,Storr Mark,Hallam Susan,Clarke Deborah,Novick Daniela,Ingham Eileen,Bowmer Christopher,Southgate Jennifer,Trejdosiewicz Ludwik K,Illingworth John,Perren Timothy J,Selby Peter J

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference47 articles.

1. Interleukin-6 in biology and medicine;Akira;Adv Immunol,1993

2. Interleukin-6 and megakaryocytopoiesis: An update;Baatout;Ann Hematol,1996

3. Interleukin-6: A cytokine with potential diagnostic and therapeutic roles;Borden;J Lab Clin Med,1994

4. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies;Weber;J Clin Oncol,1993

5. Effects of recombinant human interleukin-6 in cancer patients: A phase I-II study;Van Gameren;Blood,1994

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exercise and Weight Management: The Role of Leptin—A Systematic Review and Update of Clinical Data from 2000–2022;Journal of Clinical Medicine;2023-07-05

2. Gastrointestinal Manifestations in Patients Infected with SARS-CoV-2;Iranian Journal of Medical Microbiology;2022-07-01

3. A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs;Frontiers in Bioinformatics;2021-09-03

4. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges;World Journal of Clinical Cases;2021-08-06

5. Systemic inflammation as fuel for acute liver injury in COVID-19;Digestive and Liver Disease;2021-02